Form 4: SIGA Director Jaymie Durnan Reports RSU Vesting

Director Jaymie Durnan exercised restricted stock units and received a new grant as part of SIGA Technologies' director compensation program.

Summary

• Director Jaymie Durnan acquired 24,116 shares of common stock upon the vesting of restricted stock units (RSUs).
• A portion of the vested RSUs, totaling 7,235 shares, was withheld for tax purposes and settled in cash at a price of $4.39 per share.
• Following these transactions, the director holds 88,754 shares of common stock.
• The director was granted a new award of 34,169 RSUs, which are scheduled to vest at the 2027 annual meeting of stockholders.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation and equity vesting.

Positives

• The transaction reflects standard equity-based compensation alignment between the director and shareholders.

Negatives

• The partial cash settlement for tax obligations results in a minor reduction of potential equity ownership compared to a full share issuance.

Risks

• Future value of equity holdings is subject to market volatility of SIGA common stock.
• Reliance on the Board's discretion for the settlement method (cash vs. shares) of the new RSU grant.

Future Outlook

The director holds 34,169 RSUs that are expected to fully vest on the date of the Company's 2027 annual meeting of stockholders.

Management Comments

• RSUs represent contingent rights to receive common stock on a one-for-one basis.
• Partial cash-settlement of RSUs is designed to address tax obligations in connection with the vesting of RSUs.

Industry Context

StockSavvy.ai notes that this filing represents routine corporate governance and director compensation activity, which is standard practice for publicly traded biotechnology firms to maintain board alignment with shareholder interests.

Comparison to Industry Standards

• The use of RSU-based compensation for board members is consistent with standard practices among mid-cap biotechnology companies.
• Tax-withholding via partial cash settlement is a common mechanism to manage director tax liabilities without requiring the sale of open-market shares.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation-related transaction.

Next Steps

• Vesting of 34,169 RSUs at the 2027 annual meeting of stockholders.

Key Dates

Keywords

SIGA Technologies, Form 4, Insider Trading, Director Compensation, Restricted Stock Units, Equity Vesting